Collectively, these findings position TRPV1 as both a disease-modifying factor and a determinant of T1D outcomes, underscoring its potential as a biomarker and therapeutic target in autoimmune diabetes. The gene discussed is TRPV1; the disease is type 1 diabetes mellitus.